Emergency transcatheter aortic valve replacement for surgical bioprosthesis structural valve degeneration: a case report_West China Medical Journal

Authors：

FANG Zhen ¹ , JI Jun ¹ , CHEN Shu ¹ , ZHANG Jing ¹ , CHEN Yong ² , BAO Ping ² ,  HE Shenghu ¹

1. Department of Cardiology, Northern Jiangsu People’s Hospital, Clinical Medical College of Yangzhou University, Yangzhou, Jiangsu 225000, P. R. China;
2. Department of Cardiac Function Examination, Northern Jiangsu People’s Hospital, Clinical Medical College of Yangzhou University, Yangzhou, Jiangsu 225000, P. R. China;

Corresponding?author：

HE Shenghu, Email: yzhshys@163.com

Keywords：

Transcatheter aortic valve replacement; bioprosthesis structural valve degeneration; valve-in-valve

DOI：

10.7507/1002-0179.202110150

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

“Valve-in-valve” technique is an effective method to treat the bioprosthesis structural valve degeneration. In this paper, an 82-year-old male patient with severe aortic valve regurgitation had underwent surgical aortic valve replacement. He had a bioprosthesis structural valve degeneration which caused severe aortic stenosis more than 3 years after surgery. His symptoms of chest distress and short breath were aggravated progressively, and not relieved by conventional treatment. As the deterioration in his unstabled circulation system, an emergency transcatheter aortic valve replacement was conducted for him. The operation was finally successful, the symptoms were relived significantly after operation, and then the follow-up indicated that he had a good recovery.

Citation： FANG Zhen, JI Jun, CHEN Shu, ZHANG Jing, CHEN Yong, BAO Ping, HE Shenghu. Emergency transcatheter aortic valve replacement for surgical bioprosthesis structural valve degeneration: a case report. West China Medical Journal, 2022, 37(4): 517-521. doi: 10.7507/1002-0179.202110150 Copy

1.	Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 2002, 106(24): 3006-3008.
2.	葛均波, 周達新, 潘文志, 等. 經皮主動脈瓣植入術一例及其操作要點. 中國介入心臟病學雜志, 2010, 18(5): 243-246.
3.	中國醫師協會心血管內科醫師分會結構性心臟病專業委員會. 經導管主動脈瓣置換術中國專家共識(2020更新版). 中國介入心臟病學雜志, 2020, 28(6): 301-309.
4.	Ferrari E. Transapical aortic ‘valve-in-valve’ procedure for degenerated stented bioprosthesis. Eur J Cardiothorac Surg, 2012, 41(3): 485-490.
5.	姜海濱. “瓣中瓣”技術在生物瓣膜衰敗治療上的應用. 心血管病學進展, 2013, 34(4): 561-564.
6.	C?té N, Pibarot P, Clavel MA. Incidence, risk factors, clinical impact, and management of bioprosthesis structural valve degeneration. Curr Opin Cardiol, 2017, 32(2): 123-129.
7.	Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA, 2014, 312(2): 162-170.
8.	楊力凡, 潘文志, 張曉春, 等. 人工生物瓣膜結構性衰敗后再次行經導管主動脈瓣置換一例. 中華心血管病雜志, 2021, 49(5): 507-509.
9.	陳鵬飛, 易俊霖, 唐亮, 等. 瓣中瓣技術在經導管主動脈瓣置入術中的應用3例報道. 中國介入心臟病學雜志, 2018, 26(11): 658-660.
10.	周達新, 潘文志, 管麗華, 等. 經導管瓣中瓣置入術治療人工生物主動脈瓣反流一例. 中華心血管病雜志, 2013, 41(9): 800-801.
11.	Webb JG, Wood DA, Ye J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation, 2010, 121(16): 1848-1857.
12.	Hirji SA, Percy ED, Zogg CK, et al. Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement:a contemporary assessment of real-world outcomes. Eur Heart J, 2020, 41(29): 2747-2755.
13.	Sá MPBO, Van den Eynde J, Simonato M, et al. Valve-in-valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement: an updated meta-analysis. JACC Cardiovasc Interv, 2021, 14(2): 211-220.
14.	Yao RJ, Simonato M, Dvir D. Optimising the haemodynamics of aortic valve-in-valve procedures. Interv Cardiol, 2017, 12(1): 40-43.
15.	Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med, 2010, 363(17): 1597-1607.
16.	李華俊, 劉先寶, 孔敏堅, 等. 經導管主動脈瓣置換圍術期Impella輔助救治主動脈瓣反流一例. 中華心血管病雜志, 2021, 49(2): 179-181.
17.	Kolte D, Khera S, Vemulapalli S, et al. Outcomes following urgent/emergent transcatheter aortic valve replacement: insights from the STS/ACC TVT registry. JACC Cardiovasc Interv, 2018, 11(12): 1175-1185.
18.	姜正明, 李光照, 胡彩娜, 等. 急診經導管主動脈瓣置換術治療重度主動脈瓣狹窄的早期臨床療效分析. 華西醫學, 2021, 36(11): 1522-1527.
19.	David TE, Feindel CM, Bos J, et al. Aortic valve replacement with Toronto SPV bioprosthesis: optimal patient survival but suboptimal valve durability. J Thorac Cardiovasc Surg, 2008, 135(1): 19-24.
20.	David TE, Ivanov J, Armstrong S, et al. Late results of heart valve replacement with the Hancock Ⅱ bioprosthesis. J Thorac Cardiovasc Surg, 2001, 121(2): 268-277.
21.	Poirer NC, Pelletier LC, Pellerin M, et al. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg, 1998, 66(6 Suppl): S57-S61.
22.	金沁純, 潘文志, 張曉春, 等. 經導管主動脈瓣置換術中瓣中瓣技術的應用進展. 復旦學報(醫學版), 2021, 48(2): 235-239.
23.	Isaacs AJ, Shuhaiber J, Salemi A, et al. National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements. J Thorac Cardiovasc Surg, 2015, 149(5): 1262-1269.
24.	武云龍, 王寅, 董念國. 瓣膜介入時代的思考—外科醫生視角. 中國胸心血管外科臨床雜志, 2021, 28(12): 1415-1419.

1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 2002, 106(24): 3006-3008.
2. 葛均波, 周達新, 潘文志, 等. 經皮主動脈瓣植入術一例及其操作要點. 中國介入心臟病學雜志, 2010, 18(5): 243-246.
3. 中國醫師協會心血管內科醫師分會結構性心臟病專業委員會. 經導管主動脈瓣置換術中國專家共識(2020更新版). 中國介入心臟病學雜志, 2020, 28(6): 301-309.
4. Ferrari E. Transapical aortic ‘valve-in-valve’ procedure for degenerated stented bioprosthesis. Eur J Cardiothorac Surg, 2012, 41(3): 485-490.
5. 姜海濱. “瓣中瓣”技術在生物瓣膜衰敗治療上的應用. 心血管病學進展, 2013, 34(4): 561-564.
6. C?té N, Pibarot P, Clavel MA. Incidence, risk factors, clinical impact, and management of bioprosthesis structural valve degeneration. Curr Opin Cardiol, 2017, 32(2): 123-129.
7. Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA, 2014, 312(2): 162-170.
8. 楊力凡, 潘文志, 張曉春, 等. 人工生物瓣膜結構性衰敗后再次行經導管主動脈瓣置換一例. 中華心血管病雜志, 2021, 49(5): 507-509.
9. 陳鵬飛, 易俊霖, 唐亮, 等. 瓣中瓣技術在經導管主動脈瓣置入術中的應用3例報道. 中國介入心臟病學雜志, 2018, 26(11): 658-660.
10. 周達新, 潘文志, 管麗華, 等. 經導管瓣中瓣置入術治療人工生物主動脈瓣反流一例. 中華心血管病雜志, 2013, 41(9): 800-801.
11. Webb JG, Wood DA, Ye J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation, 2010, 121(16): 1848-1857.
12. Hirji SA, Percy ED, Zogg CK, et al. Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement:a contemporary assessment of real-world outcomes. Eur Heart J, 2020, 41(29): 2747-2755.
13. Sá MPBO, Van den Eynde J, Simonato M, et al. Valve-in-valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement: an updated meta-analysis. JACC Cardiovasc Interv, 2021, 14(2): 211-220.
14. Yao RJ, Simonato M, Dvir D. Optimising the haemodynamics of aortic valve-in-valve procedures. Interv Cardiol, 2017, 12(1): 40-43.
15. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med, 2010, 363(17): 1597-1607.
16. 李華俊, 劉先寶, 孔敏堅, 等. 經導管主動脈瓣置換圍術期Impella輔助救治主動脈瓣反流一例. 中華心血管病雜志, 2021, 49(2): 179-181.
17. Kolte D, Khera S, Vemulapalli S, et al. Outcomes following urgent/emergent transcatheter aortic valve replacement: insights from the STS/ACC TVT registry. JACC Cardiovasc Interv, 2018, 11(12): 1175-1185.
18. 姜正明, 李光照, 胡彩娜, 等. 急診經導管主動脈瓣置換術治療重度主動脈瓣狹窄的早期臨床療效分析. 華西醫學, 2021, 36(11): 1522-1527.
19. David TE, Feindel CM, Bos J, et al. Aortic valve replacement with Toronto SPV bioprosthesis: optimal patient survival but suboptimal valve durability. J Thorac Cardiovasc Surg, 2008, 135(1): 19-24.
20. David TE, Ivanov J, Armstrong S, et al. Late results of heart valve replacement with the Hancock Ⅱ bioprosthesis. J Thorac Cardiovasc Surg, 2001, 121(2): 268-277.
21. Poirer NC, Pelletier LC, Pellerin M, et al. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg, 1998, 66(6 Suppl): S57-S61.
22. 金沁純, 潘文志, 張曉春, 等. 經導管主動脈瓣置換術中瓣中瓣技術的應用進展. 復旦學報(醫學版), 2021, 48(2): 235-239.
23. Isaacs AJ, Shuhaiber J, Salemi A, et al. National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements. J Thorac Cardiovasc Surg, 2015, 149(5): 1262-1269.
24. 武云龍, 王寅, 董念國. 瓣膜介入時代的思考—外科醫生視角. 中國胸心血管外科臨床雜志, 2021, 28(12): 1415-1419.

West China Medical Journal

Emergency transcatheter aortic valve replacement for surgical bioprosthesis structural valve degeneration: a case report

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content